Carcinoma, Renal Cell: all 1,992 studies
Page 15 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.
- Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell CarcinomaCompletedNCT02489695Phase 2
- PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKITerminatedNCT02479490Phase 2
- Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCCActive, not recruitingNCT02473536Phase 1/2
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- ImmuniCell® in Patients With Advanced CancersTerminatedNCT02459067Phase 2
- A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)TerminatedNCT02446860Phase 2
- Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II TrialStatus unknownNCT02446795Phase 1/2
- Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
- Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated PeptidesStatus unknownNCT02429440Phase 1/2
- Study of Muscle Energy Metabolism in RCC Patients Treated With SunitinibWithdrawnNCT02428335
- Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)TerminatedNCT02423954Phase 1/2
- Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
- Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell CarcinomaStatus unknownNCT02417194
- Follow up After Cryoablation of Small Renal Masses.CompletedNCT02411968
- To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma TumorsTerminatedNCT02410174Phase 1
- Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone MetsCompletedNCT02406521Phase 1
- Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell CarcinomaActive, not recruitingNCT02399124Not applicable
- A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.Status unknownNCT02398552Phase 2
- A Study of rSIFN-co in Subjects With Advanced Solid TumorsCompletedNCT02387307Phase 1
- INC280 Combined With Bevacizumab in Patients With Glioblastoma MultiformeCompletedNCT02386826Phase 1
- A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaTerminatedNCT02386111Phase 1
- Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health InterventionCompletedNCT02375776Not applicable
- Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing SurgeryWithdrawnNCT02370342Not applicable
- Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney CancerCompletedNCT02370290
- Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)CompletedNCT02363751Phase 2
- Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)TerminatedNCT02338570Phase 4
- A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid TumorsCompletedNCT02335918Phase 1/2
- Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.CompletedNCT02334709Phase 1/2
- Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer PatientsStatus unknownNCT02330783Phase 2
- Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell CarcinomaCompletedNCT02326558Not applicable
- MRI in Renal TumorsCompletedNCT02325921
- Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC PatientsStatus unknownNCT02324803Phase 2
- Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung CancerCompletedNCT02318771Phase 1
- A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell CancerWithdrawnNCT02307474Not applicable
- Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal CancerActive, not recruitingNCT02306954Phase 2
- Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerActive, not recruitingNCT02298959Phase 1
- Efficacy and Safety of IRE for RMsStatus unknownNCT02298608Phase 1/2
- A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)Active, not recruitingNCT02293980Phase 1
- Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line TherapyCompletedNCT02282579
- A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative RadiotherapyCompletedNCT02264548Phase 1
- Evaluation of a Laparoscopic High Intensity Focused Ultrasound Probe for the Ablation of Small Renal MassesCompletedNCT02248389Phase 1
- Investigating Patient Satisfaction With Oral Anti-Cancer TreatmentCompletedNCT02247583
- A Study of BBI503 in Adult Patients With Advanced Urologic MalignanciesWithdrawnNCT02232646Phase 2
- IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)CompletedNCT02228954
- Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCompletedNCT02223052Phase 1
- Safety Study of SGN-CD70A in Cancer PatientsCompletedNCT02216890Phase 1
- Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by SurgeryActive, not recruitingNCT02210117Early Phase 1
- Molecular Determinants for Therapy Response on Renal Cell CarcinomaStatus unknownNCT02208128Not applicable
- CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)CompletedNCT02187302Phase 2
- Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life SettingCompletedNCT02184416
- APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT02166255Phase 1
- Dual Energy CT vs Standard Triple Phase CT-A Randomised Control TrialCompletedNCT02160600Not applicable
- Interleukin-2-Induced Cognitive/Affective/Sleep SymptomsCompletedNCT02150369
- A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid TumorsCompletedNCT02145559Phase 1
- Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCCCompletedNCT02143492
- Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical RenorrhaphyTerminatedNCT02131376Not applicable
- Second Line Sorafenib After Pazopanib in Patients With RCCTerminatedNCT02122003Phase 2
- Optimizing Pazopanib Exposure in RCC PatientsTerminatedNCT02089802Phase 2
- Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell CarcinomaCompletedNCT02086734
- Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)CompletedNCT02080650Not applicable
- Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsCompletedNCT02077933Phase 1
- Optical Biopsy to Improve the Diagnosis of Kidney CancerStatus unknownNCT02073110
- Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs TherapyStatus unknownNCT02072044Phase 2
- Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）Status unknownNCT02072031Phase 2
- Study of the Glutaminase Inhibitor CB-839 in Solid TumorsCompletedNCT02071862Phase 1
- Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer PatientsTerminatedNCT02071719
- Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT02071641Phase 2
- First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial NephrectomyWithdrawnNCT02061605Not applicable
- Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab TreatmentCompletedNCT02056587Phase 4
- Mechanism of Action Trial of ColoAd1CompletedNCT02053220Phase 1
- Immunotherapy Study for Metastatic Renal Cell CancerCompletedNCT02035358Phase 1
- Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell CarcinomaCompletedNCT02030717Phase 2/3
- RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)TerminatedNCT02026960Not applicable
- Value of Various Chemokines in the Detection and Follow up of RCCStatus unknownNCT02022787
- Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With SunitinibCompletedNCT02019576Phase 2
- Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal TumoursCompletedNCT02016391Phase 4
- Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)CompletedNCT02014636Phase 1
- A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose SelectionTerminatedNCT02005614Not applicable
- Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal CancerCompletedNCT02002312Phase 2
- Metabolomic Profiling in Renal Cell CarcinomaStatus unknownNCT02001493
- The Intrathecal Morphine for NephrectomyCompletedNCT01997788Not applicable
- Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01982097
- Functional Imaging in the Assessment of mRCC Response to SunitinibWithdrawnNCT01977586Not applicable
- IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.Status unknownNCT01967407Phase 1/2
- Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney CancerTerminatedNCT01943188Phase 1
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell CarcinomaCompletedNCT01926990
- Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2TerminatedNCT01925118Phase 2
- DC Vaccine Combined With CIK Cells in Patients With Renal Cell CarcinomaStatus unknownNCT01924156Phase 1/2
- Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical ResectionStatus unknownNCT01914263Phase 1
- Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing SurgeryCompletedNCT01892930Not applicable
- Study of Segmental Renal Artery Clamping During Laparoscopic Partial NephrectomyStatus unknownNCT01892059Not applicable
- Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney CancerTerminatedNCT01888042Phase 2
- Renal Mass RegistryCompletedNCT01887574Not applicable
- Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2CompletedNCT01884961Phase 2
- Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersCompletedNCT01846520Not applicable
- Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a StageStatus unknownNCT01838720Not applicable
- Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial NephrectomyCompletedNCT01836406Not applicable
- Tivozanib + Gemcitabine in Metastatic RCCWithdrawnNCT01834183Phase 2
- A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC PatientsCompletedNCT01831973Phase 2